Regenicin, Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 0.277514 million compared to USD 0.154125 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -98.00% | +4,900.00% | +499,900.00% |
1st Jan change | Capi. | |
---|---|---|
+499,900.00% | 767K | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- RGIN Stock
- News Regenicin, Inc.
- Regenicin, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022